Eosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronóstica

51 Páginas.

Autores:: Orozco Araujo, Silvana
Guerra Malaver, Nelcy Teresa

Tipo de recurso:

Fecha de publicación:: 2011

Institución:: Universidad de la Sabana

Repositorio:: Repositorio Universidad de la Sabana

Idioma:: spa

id	REPOUSABA2_3294d1069b2bb9fae965109bd7db0b46
oai_identifier_str	oai:intellectum.unisabana.edu.co:10818/1300
network_acronym_str	REPOUSABA2
network_name_str	Repositorio Universidad de la Sabana
repository_id_str
dc.title.es_CO.fl_str_mv	Eosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronóstica
title	Eosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronóstica
spellingShingle	Eosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronóstica Síndrome de respuesta inflamatoria sistémica-Investigaciones Eosinopenia-Investigaciones
title_short	Eosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronóstica
title_full	Eosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronóstica
title_fullStr	Eosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronóstica
title_full_unstemmed	Eosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronóstica
title_sort	Eosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronóstica
dc.creator.fl_str_mv	Orozco Araujo, Silvana Guerra Malaver, Nelcy Teresa
dc.contributor.advisor.none.fl_str_mv	Pérez, Carlos Granados, Carlos Eduardo
dc.contributor.author.none.fl_str_mv	Orozco Araujo, Silvana Guerra Malaver, Nelcy Teresa
dc.subject.es_CO.fl_str_mv	Síndrome de respuesta inflamatoria sistémica-Investigaciones Eosinopenia-Investigaciones
topic	Síndrome de respuesta inflamatoria sistémica-Investigaciones Eosinopenia-Investigaciones
description	51 Páginas.
publishDate	2011
dc.date.created.none.fl_str_mv	2011
dc.date.accessioned.none.fl_str_mv	2012-03-06T20:06:43Z
dc.date.available.none.fl_str_mv	2012-03-06T20:06:43Z
dc.date.issued.none.fl_str_mv	2012-03-06
dc.type.none.fl_str_mv	bachelorThesis
dc.type.coarversion.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_7a1f
dc.type.local.none.fl_str_mv	Tesis de especialización
dc.type.hasVersion.none.fl_str_mv	publishedVersion
dc.identifier.citation.none.fl_str_mv	Wintrobe, M, Wintrobe’s Clinical Hematology, Lippincott williams y wilkins, Philadelphia, 12th edition, 2009 Fauci A y cols, Harrison’s principles of internal medicine, McGraw-Hill”s, 17th edition, 2008 Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood. 79, 3101- 3109, 1992 E Cecchini y cols, Infectologia y Enfermedades Infecciosas, Futuro, 2007 Abbas A, Lichtman, Inmunologia cellular y molecular 6 ed, Elsevier, 2009 Morgan JE, Beeson PB. Experimental observations on the eosinopenia induced by acute infection. Br J Exp Pathol, 52(2):214–220, 1971. Weber H, A quantitative study of eosinopenia and other stress indices. The Journal of sports medicine and physical fitness, 11/1(12-23), March 1971 López-Osuna M, Cárdenas G, Increased susceptibility to experimental amebic abscess of the liver in gerbils (Meriones unguiculatus) with induced eosinopenia. Archives of medical research, v31/4, July 2000 Roberts WC, Liegler DG, Carbone PP. Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med. Jan;46(1):28–42. 1969 Weiner HA, Morkovin D. Circulating blood eosinophils in acute infectious disease and the eosinopenic response. Am J Med.;13(1):58–72, 1952 Tartakovskiĭ MB, Kanter IR, Syndromes associated with eosinopenia. Freeman GL Allergy, vol./is. 53/3(331-3), 1998 S D Burdette, M A Parilo, Systemic Inflammatory Response Syndrome, Critical Care, Medical College of Pennsylvania Hahnemann University Rangel-Fausto, Pittet D, Costigan M. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 273:117-123, 1995 Bone RC. Systemic inflammatory response syndrome: a unifying concept of systemic inflammation. Sepsis and Multiorgan Failure. Philadelphia, 1-10, 1997. Bone RC, Balk RA, Cerra FC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest.;101:1644-1655, 1992 Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg.;84(7):920-35, Jul 1997 Baue AE. Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets?. Arch Sur;132(7):703, Jul 1997 Bone RC, Balk RA, Cerra FC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 101:1644-1655, 1992 Early goal-directed therapy in the treatment of severe sepsis and septic chock. N Engl J Med, Vol. 345, No. 19 November 8, 2001 Shapiro N, Howell MD, Bates DW. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med. 48:583-590, 2006 Whitcomb C, Acute Pancreatitis, N Engl J Med; 354:2142-50, 2006 Hirai S. Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass. Ann Thorac Cardiovasc Surg. 9:365- 370, 2003 Wolf I, Mouallem M, Rath S. Clopidogrel-induced systemic inflammatory response syndrome. Mayo Clin Proc. 78:618-620, 2003 Thomas Korn, Vijay K. Kuchroo, Mechanisms of Disease Interleukin-17 and Type 17 Helper T Cells Pierre Miossec, N Engl J Med, 361:888- 98, 2009 L Williams, Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin, Critical Care Medicine Vol 28, 8, 2000 Bass DA. Behavior of eosinophil leukocytes in acute inflammation. Eosinophil dynamics during acute inflammation. J Clin Invest. Oct;56(4):870–875, 1975 Bass D and cols, Eosinopenia of Acute Infection, J clin Invest, V 65, 1265-1271, 1980 Ho kM, A comparison of eosinopenia and C-reactive protein as a marker of bloodstream infections in critically ill patients: a case control study. Anaesthesia and intensive care, vol./is. 37/3(450-6), May 2009 Henry Wl Jr, Oliner L, Relationship between actions of adrenocortical steroids and adrenomedullary hormones in the production of eosinopenia. Am J Physiol. 174(3):455–458, 1953 Holzmann H, Korting GW, On the effect of testosterone on the eosinophil count and dexamethasone-induced eosinopenia in man, Archiv fur klinische und experimentelle Dermatologie,(523-30), 1960 Holzmann H, Korting GW, On differences in eosinopenia caused by dexamethasone in dependence on the method of administration. Archiv fur klinische und experimentelle Dermatologie,(418-26), 1960 Morandi L and cols, The mechanism of insulin eosinopenia, vol./is. 35/20, 1957 Morandi L and cols, Mechanism of adrenalin- and insulin-induced eosinopenia. Helvetica medica acta, vol./is. 24/4(482-7), October 1957 Dellinger P, Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, Critical Care Medicine , Vol 36, Issue 1, January 2008 Anil Potti, and Raymond A. Smego, Utility of Eosinophil Count as Predictor of Bacteremia,Clin Infect Dis, Vol 38, 460-461,1971 Gil H and cols, Value of eosinopenia in inflammatory disorders: an “old’ marker revisited, Rev med Interne, 24(7), 431-5, 2003 Alkhalil M and cols, Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease.Holland M, Respirology, (15) 165-167, 2010 Stamatis P, Angelo V et al. Fever of unknown origin: Discrimination between infectious and non infectious causes. European Journal of Internal Medicine. 21 137-143, 2010 Hamid Shaaban and cols, Eosinopenia: is it a good marker of sepsis in comparison to procalcitonin and C-reative protein levels for patients to a critical care unit in an urban hospital?, Journal Of critical care, 25, 570-575, 2010 A Smithson, Is eosinopenia a reliable marker of sepsis?, critical care, 13: 409, 2009 Mokart D, Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. British journal of anaesthesia, 94(6), 767-73, 2005 Isabel NH, Eosinofilia y parasitosis, Rev chil pediatr, 70 (5), 1999 Abidi K and cols, Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units, Critical Care,12 (2), 1-10, 2008 Trauma prioridades, Sociedad argentina de medicina y cirugia del trauma, editorial panamericana 2002, pag 96
dc.identifier.uri.none.fl_str_mv	http://hdl.handle.net/10818/1300
dc.identifier.local.none.fl_str_mv	142363 TE00051
identifier_str_mv	Wintrobe, M, Wintrobe’s Clinical Hematology, Lippincott williams y wilkins, Philadelphia, 12th edition, 2009 Fauci A y cols, Harrison’s principles of internal medicine, McGraw-Hill”s, 17th edition, 2008 Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood. 79, 3101- 3109, 1992 E Cecchini y cols, Infectologia y Enfermedades Infecciosas, Futuro, 2007 Abbas A, Lichtman, Inmunologia cellular y molecular 6 ed, Elsevier, 2009 Morgan JE, Beeson PB. Experimental observations on the eosinopenia induced by acute infection. Br J Exp Pathol, 52(2):214–220, 1971. Weber H, A quantitative study of eosinopenia and other stress indices. The Journal of sports medicine and physical fitness, 11/1(12-23), March 1971 López-Osuna M, Cárdenas G, Increased susceptibility to experimental amebic abscess of the liver in gerbils (Meriones unguiculatus) with induced eosinopenia. Archives of medical research, v31/4, July 2000 Roberts WC, Liegler DG, Carbone PP. Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med. Jan;46(1):28–42. 1969 Weiner HA, Morkovin D. Circulating blood eosinophils in acute infectious disease and the eosinopenic response. Am J Med.;13(1):58–72, 1952 Tartakovskiĭ MB, Kanter IR, Syndromes associated with eosinopenia. Freeman GL Allergy, vol./is. 53/3(331-3), 1998 S D Burdette, M A Parilo, Systemic Inflammatory Response Syndrome, Critical Care, Medical College of Pennsylvania Hahnemann University Rangel-Fausto, Pittet D, Costigan M. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 273:117-123, 1995 Bone RC. Systemic inflammatory response syndrome: a unifying concept of systemic inflammation. Sepsis and Multiorgan Failure. Philadelphia, 1-10, 1997. Bone RC, Balk RA, Cerra FC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest.;101:1644-1655, 1992 Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg.;84(7):920-35, Jul 1997 Baue AE. Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets?. Arch Sur;132(7):703, Jul 1997 Bone RC, Balk RA, Cerra FC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 101:1644-1655, 1992 Early goal-directed therapy in the treatment of severe sepsis and septic chock. N Engl J Med, Vol. 345, No. 19 November 8, 2001 Shapiro N, Howell MD, Bates DW. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med. 48:583-590, 2006 Whitcomb C, Acute Pancreatitis, N Engl J Med; 354:2142-50, 2006 Hirai S. Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass. Ann Thorac Cardiovasc Surg. 9:365- 370, 2003 Wolf I, Mouallem M, Rath S. Clopidogrel-induced systemic inflammatory response syndrome. Mayo Clin Proc. 78:618-620, 2003 Thomas Korn, Vijay K. Kuchroo, Mechanisms of Disease Interleukin-17 and Type 17 Helper T Cells Pierre Miossec, N Engl J Med, 361:888- 98, 2009 L Williams, Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin, Critical Care Medicine Vol 28, 8, 2000 Bass DA. Behavior of eosinophil leukocytes in acute inflammation. Eosinophil dynamics during acute inflammation. J Clin Invest. Oct;56(4):870–875, 1975 Bass D and cols, Eosinopenia of Acute Infection, J clin Invest, V 65, 1265-1271, 1980 Ho kM, A comparison of eosinopenia and C-reactive protein as a marker of bloodstream infections in critically ill patients: a case control study. Anaesthesia and intensive care, vol./is. 37/3(450-6), May 2009 Henry Wl Jr, Oliner L, Relationship between actions of adrenocortical steroids and adrenomedullary hormones in the production of eosinopenia. Am J Physiol. 174(3):455–458, 1953 Holzmann H, Korting GW, On the effect of testosterone on the eosinophil count and dexamethasone-induced eosinopenia in man, Archiv fur klinische und experimentelle Dermatologie,(523-30), 1960 Holzmann H, Korting GW, On differences in eosinopenia caused by dexamethasone in dependence on the method of administration. Archiv fur klinische und experimentelle Dermatologie,(418-26), 1960 Morandi L and cols, The mechanism of insulin eosinopenia, vol./is. 35/20, 1957 Morandi L and cols, Mechanism of adrenalin- and insulin-induced eosinopenia. Helvetica medica acta, vol./is. 24/4(482-7), October 1957 Dellinger P, Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, Critical Care Medicine , Vol 36, Issue 1, January 2008 Anil Potti, and Raymond A. Smego, Utility of Eosinophil Count as Predictor of Bacteremia,Clin Infect Dis, Vol 38, 460-461,1971 Gil H and cols, Value of eosinopenia in inflammatory disorders: an “old’ marker revisited, Rev med Interne, 24(7), 431-5, 2003 Alkhalil M and cols, Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease.Holland M, Respirology, (15) 165-167, 2010 Stamatis P, Angelo V et al. Fever of unknown origin: Discrimination between infectious and non infectious causes. European Journal of Internal Medicine. 21 137-143, 2010 Hamid Shaaban and cols, Eosinopenia: is it a good marker of sepsis in comparison to procalcitonin and C-reative protein levels for patients to a critical care unit in an urban hospital?, Journal Of critical care, 25, 570-575, 2010 A Smithson, Is eosinopenia a reliable marker of sepsis?, critical care, 13: 409, 2009 Mokart D, Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. British journal of anaesthesia, 94(6), 767-73, 2005 Isabel NH, Eosinofilia y parasitosis, Rev chil pediatr, 70 (5), 1999 Abidi K and cols, Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units, Critical Care,12 (2), 1-10, 2008 Trauma prioridades, Sociedad argentina de medicina y cirugia del trauma, editorial panamericana 2002, pag 96 142363 TE00051
url	http://hdl.handle.net/10818/1300
dc.language.iso.es_CO.fl_str_mv	spa
language	spa
dc.rights.coar.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	http://purl.org/coar/access_right/c_abf2
dc.publisher.none.fl_str_mv	Universidad de La Sabana
dc.publisher.program.none.fl_str_mv	Especialización en Medicina Interna
dc.publisher.department.none.fl_str_mv	Facultad de Medicina
publisher.none.fl_str_mv	Universidad de La Sabana
dc.source.none.fl_str_mv	Universidad de La Sabana Intellectum Repositorio Universidad de La Sabana
institution	Universidad de la Sabana
bitstream.url.fl_str_mv	https://intellectum.unisabana.edu.co/bitstream/10818/1300/1/Silvana%20Orozco%20Araujo.pdf https://intellectum.unisabana.edu.co/bitstream/10818/1300/2/license.txt https://intellectum.unisabana.edu.co/bitstream/10818/1300/3/Silvana%20Orozco%20Araujo.pdf.txt
bitstream.checksum.fl_str_mv	b0592e629fea30bbe74a797618ba28c1 f52a2cfd4df262e08e9b300d62c85cab 8784f312b271a192ac57265c160388a3
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5
repository.name.fl_str_mv	Intellectum Universidad de la Sabana
repository.mail.fl_str_mv	contactointellectum@unisabana.edu.co
_version_	1811952210494357504
spelling	Pérez, CarlosGranados, Carlos EduardoOrozco Araujo, SilvanaGuerra Malaver, Nelcy TeresaEspecialización en Medicina Interna2012-03-06T20:06:43Z2012-03-06T20:06:43Z20112012-03-06Wintrobe, M, Wintrobe’s Clinical Hematology, Lippincott williams y wilkins, Philadelphia, 12th edition, 2009Fauci A y cols, Harrison’s principles of internal medicine, McGraw-Hill”s, 17th edition, 2008Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood. 79, 3101- 3109, 1992E Cecchini y cols, Infectologia y Enfermedades Infecciosas, Futuro, 2007Abbas A, Lichtman, Inmunologia cellular y molecular 6 ed, Elsevier, 2009Morgan JE, Beeson PB. Experimental observations on the eosinopenia induced by acute infection. Br J Exp Pathol, 52(2):214–220, 1971.Weber H, A quantitative study of eosinopenia and other stress indices. The Journal of sports medicine and physical fitness, 11/1(12-23), March 1971López-Osuna M, Cárdenas G, Increased susceptibility to experimental amebic abscess of the liver in gerbils (Meriones unguiculatus) with induced eosinopenia. Archives of medical research, v31/4, July 2000Roberts WC, Liegler DG, Carbone PP. Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med. Jan;46(1):28–42. 1969Weiner HA, Morkovin D. Circulating blood eosinophils in acute infectious disease and the eosinopenic response. Am J Med.;13(1):58–72, 1952Tartakovskiĭ MB, Kanter IR, Syndromes associated with eosinopenia. Freeman GL Allergy, vol./is. 53/3(331-3), 1998S D Burdette, M A Parilo, Systemic Inflammatory Response Syndrome, Critical Care, Medical College of Pennsylvania Hahnemann UniversityRangel-Fausto, Pittet D, Costigan M. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 273:117-123, 1995Bone RC. Systemic inflammatory response syndrome: a unifying concept of systemic inflammation. Sepsis and Multiorgan Failure. Philadelphia, 1-10, 1997.Bone RC, Balk RA, Cerra FC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest.;101:1644-1655, 1992Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg.;84(7):920-35, Jul 1997Baue AE. Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets?. Arch Sur;132(7):703, Jul 1997Bone RC, Balk RA, Cerra FC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 101:1644-1655, 1992Early goal-directed therapy in the treatment of severe sepsis and septic chock. N Engl J Med, Vol. 345, No. 19 November 8, 2001Shapiro N, Howell MD, Bates DW. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med. 48:583-590, 2006Whitcomb C, Acute Pancreatitis, N Engl J Med; 354:2142-50, 2006Hirai S. Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass. Ann Thorac Cardiovasc Surg. 9:365- 370, 2003Wolf I, Mouallem M, Rath S. Clopidogrel-induced systemic inflammatory response syndrome. Mayo Clin Proc. 78:618-620, 2003Thomas Korn, Vijay K. Kuchroo, Mechanisms of Disease Interleukin-17 and Type 17 Helper T Cells Pierre Miossec, N Engl J Med, 361:888- 98, 2009L Williams, Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin, Critical Care Medicine Vol 28, 8, 2000Bass DA. Behavior of eosinophil leukocytes in acute inflammation. Eosinophil dynamics during acute inflammation. J Clin Invest. Oct;56(4):870–875, 1975Bass D and cols, Eosinopenia of Acute Infection, J clin Invest, V 65, 1265-1271, 1980Ho kM, A comparison of eosinopenia and C-reactive protein as a marker of bloodstream infections in critically ill patients: a case control study. Anaesthesia and intensive care, vol./is. 37/3(450-6), May 2009Henry Wl Jr, Oliner L, Relationship between actions of adrenocortical steroids and adrenomedullary hormones in the production of eosinopenia. Am J Physiol. 174(3):455–458, 1953Holzmann H, Korting GW, On the effect of testosterone on the eosinophil count and dexamethasone-induced eosinopenia in man, Archiv fur klinische und experimentelle Dermatologie,(523-30), 1960Holzmann H, Korting GW, On differences in eosinopenia caused by dexamethasone in dependence on the method of administration. Archiv fur klinische und experimentelle Dermatologie,(418-26), 1960Morandi L and cols, The mechanism of insulin eosinopenia, vol./is. 35/20, 1957Morandi L and cols, Mechanism of adrenalin- and insulin-induced eosinopenia. Helvetica medica acta, vol./is. 24/4(482-7), October 1957Dellinger P, Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, Critical Care Medicine , Vol 36, Issue 1, January 2008Anil Potti, and Raymond A. Smego, Utility of Eosinophil Count as Predictor of Bacteremia,Clin Infect Dis, Vol 38, 460-461,1971Gil H and cols, Value of eosinopenia in inflammatory disorders: an “old’ marker revisited, Rev med Interne, 24(7), 431-5, 2003Alkhalil M and cols, Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease.Holland M, Respirology, (15) 165-167, 2010Stamatis P, Angelo V et al. Fever of unknown origin: Discrimination between infectious and non infectious causes. European Journal of Internal Medicine. 21 137-143, 2010Hamid Shaaban and cols, Eosinopenia: is it a good marker of sepsis in comparison to procalcitonin and C-reative protein levels for patients to a critical care unit in an urban hospital?, Journal Of critical care, 25, 570-575, 2010A Smithson, Is eosinopenia a reliable marker of sepsis?, critical care, 13: 409, 2009Mokart D, Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. British journal of anaesthesia, 94(6), 767-73, 2005Isabel NH, Eosinofilia y parasitosis, Rev chil pediatr, 70 (5), 1999Abidi K and cols, Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units, Critical Care,12 (2), 1-10, 2008Trauma prioridades, Sociedad argentina de medicina y cirugia del trauma, editorial panamericana 2002, pag 96http://hdl.handle.net/10818/1300142363TE0005151 Páginas.Este estudio determina la prevalencia de eosinopenia en SIRS, sus características operativas y su asociación con complicaciones. Se revisaron 335 pacientes con SIRS encontrando una prevalencia de 43,6% de eosinopenia. Los pacientes con SIRS-I con eosinopenia mostraron una mayor frecuencia de requerimiento de soporte ventilatorio (21,5%) y vasopresor (22%) con respecto al grupo de SIRS-I sin eosinopenia. La mortalidad en el grupo con SIRS-NI con eosinopenia fue significativamente mayor (27%) que en el grupo de SIRS sin eosinopenia (16,5%) p0,06. La eosinopenia tiene un bajo rendimiento para ayudar a diferenciar SIRS-I de SIRS-NI, sin embargo existe asociación entre eosinopenia en pacientes con SIRS de cualquier etiología y desenlaces clínicos adversos, tales como mortalidad y necesidad de soporte avanzado.spaUniversidad de La SabanaEspecialización en Medicina InternaFacultad de MedicinaUniversidad de La SabanaIntellectum Repositorio Universidad de La SabanaSíndrome de respuesta inflamatoria sistémica-InvestigacionesEosinopenia-InvestigacionesEosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronósticabachelorThesisTesis de especializaciónpublishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/access_right/c_abf2ORIGINALSilvana Orozco Araujo.pdfSilvana Orozco Araujo.pdfVer documento en PDFapplication/pdf390078https://intellectum.unisabana.edu.co/bitstream/10818/1300/1/Silvana%20Orozco%20Araujo.pdfb0592e629fea30bbe74a797618ba28c1MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-8498https://intellectum.unisabana.edu.co/bitstream/10818/1300/2/license.txtf52a2cfd4df262e08e9b300d62c85cabMD52TEXTSilvana Orozco Araujo.pdf.txtSilvana Orozco Araujo.pdf.txtExtracted Texttext/plain43114https://intellectum.unisabana.edu.co/bitstream/10818/1300/3/Silvana%20Orozco%20Araujo.pdf.txt8784f312b271a192ac57265c160388a3MD5310818/1300oai:intellectum.unisabana.edu.co:10818/13002021-05-28 17:22:51.355Intellectum Universidad de la Sabanacontactointellectum@unisabana.edu.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

Eosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronóstica

Publicaciones similares